VITAMED AS
Score · fiscal year 2025
Not enough data: Not enough data (below minimum revenue)
Based on the annual accounts for 2025
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 1 MNOK | 4 MNOK |
| Operating margin | 7.1% | 2.6% |
| Profit margin | 6.6% | 2.2% |
| Return on assets | 6.8% | 6.2% |
| Equity ratio | −46.0% | 33.8% |
| Debt-to-equity | – | 1.23 |
| Current ratio | 0.65 | 1.75 |
| Revenue growth | 27.6% | 4.0% |
The median and “ahead of” refer to companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
Score over time
Score over time needs at least two fiscal years with a score. It will appear when next year's figures are fetched or history is imported.
What the numbers say
VITAMED AS had an equity ratio of −46.0% in 2025. The company is not ranked: not enough data (below minimum revenue).
From 2024 to 2025: the operating margin fell from 16.7% to 7.1% and revenue grew by 28%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 1 MNOK and 1 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 1 MNOK |
| EV/EBIT | 8.0 | 1 MNOK |
| P/B | 1.0 | not meaningful |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- critical
Equity is negative. How will it be rebuilt, and what do lenders and the auditor say about going concern?
Based on: Equity ratio −46.0% (median 33.8%).
- watch
Consider strengthening liquidity: current liabilities are 1.5 times current assets.
Based on: Current ratio 0.65 (median 1.75).
- watch
Strong growth with weak liquidity. Is the growth financed, or does it tie up capital the company does not have?
Based on: Revenue growth 27.6% (median 4.0%); Current ratio 0.65 (median 1.75).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.3% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
- critical Negative equity
Scenario analysis: the sector's weakest year
We have no accounts for 2022, the sector's weakest year, for this company.
The sector's weakest year was 2022, with a median operating margin of 1.5%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
Questions and answers
How profitable is VITAMED AS?
The operating margin was 7.1% in 2025, against a median of 2.6% among companies in the same sector. Return on assets was 6.8%.
How solid is VITAMED AS?
The equity ratio was −46.0% in 2025 (median 33.8%). Equity is negative, so liabilities exceed assets.
What is the liquidity of VITAMED AS like?
The current ratio was 0.65 in 2025 (median 1.75). Current assets did not cover current liabilities.
From the Central Coordinating Register
- Org. no.
- 987188766
- Legal form
- AS
- Sector
- Handel (47.730)
- Morning company class
- Micro
- Employees
- 0–4 (not registered)
- Founded
- 1 August 2004 22 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Strømnesåsen 9, 1735 VARTEIG (SARPSBORG)
- Municipality
- Sarpsborg rank 10 of 10 in KOSTRA group 11
- Audit
- Audit opted out from 9 January 2014
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chair of the board
- Bjørn Arild Skjeltorp Sælid
- Deputy member
- Eline Lund Sælid
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 29 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 10 | – | – | |
| Rank | 20,045 | – | – | |
| Operating margin | −8.5% | 16.7% | 7.1% | |
| Return on assets | −6.0% | 12.2% | 6.8% | |
| Equity ratio | −35.9% | −58.4% | −46.0% | |
| Current ratio | 0.71 | 0.61 | 0.65 | |
| Revenue growth | – | −40.8% | 27.6% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 1.1 MNOK | 0.6 MNOK | 0.8 MNOK |
| Operating profit | −0.1 MNOK | 0.1 MNOK | 0.1 MNOK |
| Profit before tax | −0.1 MNOK | 0.1 MNOK | 0.1 MNOK |
| Net profit | −0.1 MNOK | 0.1 MNOK | 0.1 MNOK |
| Financial expenses | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Total assets | 1.5 MNOK | 0.7 MNOK | 0.8 MNOK |
| Current assets | 1.4 MNOK | 0.7 MNOK | 0.8 MNOK |
| Equity | −0.5 MNOK | −0.4 MNOK | −0.4 MNOK |
| Retained earnings | −0.6 MNOK | −0.5 MNOK | −0.5 MNOK |
| Total liabilities | 2.0 MNOK | 1.2 MNOK | 1.2 MNOK |
| Current liabilities | 2.0 MNOK | 1.2 MNOK | 1.2 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 29 October 2026, accounts id 6666152.